Scott Morgan

Associate Professor

University of Ottawa

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Scott Morgan is an Associate Professor at the University of Ottawa, Canada. His research focuses on prostate cancer, with recent articles addressing patient-reported outcomes, treatment paradigms, and prognostic models in localized and metastatic cases. He has contributed significantly to understanding the effectiveness of various therapies in real-world settings and their impact on patients' quality of life.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Katherine Virgo

Adjunct Full Professor

Emory University

UNITED STATES

View details

Christopher J.D. Wallis

CANADA

View details

Daniel E Spratt

University Hospitals Seidman Cancer Center

UNITED STATES

View details

Sebastien Hotte

McMaster University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Scott Morgan

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada

Association of Baseline Patient-reported Health-related Quality of Life Metrics with Outcome in Localised Prostate Cancer

Association of Short-Term Patient-Reported Outcomes With Long-Term Oncologic Outcomes in Localized Prostate Cancer Patients Treated With Radiation Therapy and Androgen Deprivation Therapy in a Randomized Controlled Trial

Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancer

Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada

Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.

Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

A Review on the Current Treatment Paradigm in High-Risk Prostate Cancer

Patient-reported Outcomes from a Phase III Randomized Controlled Trial Exploring Optimal Sequencing of Short-term Androgen Deprivation Therapy with Prostate Radiotherapy in Localized Prostate Cancer.

Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer

Collaborators (4)

Katherine Virgo

Christopher J.D. Wallis

Daniel E Spratt

Sebastien Hotte

Make your next move.